Calabresi P, Chabner BA: Chemotherapy of neoplastic diseases. In: Hardman J, Limbird LE (eds.): Goodman & Gilman’s: The Pharmacological Basis of Therapeutics, 9th edition. Saint Louis: McGraw Hill, 1996.
2.
Gale KE, Andersen JW, Tormey DC, et al.: Hormonal treatment for metastatic breast cancer. An Eastern Cooperative Oncology Group Phase III trial comparing aminoglutethimide to tamoxifen. Cancer. 1994; 73: 354-361.
3.
Bellet M, Alonso C, Ojeda B: Breast cancer in the elderly. Postgrad Med J. 1995; 71: 658-664.
4.
Bernhard J, Thurlimann B, Schmitz SF, et al.: Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: Does quality of life matter?J Clin Oncol. 1999; 17: 1672-1679.
5.
Rich SE: Tamoxifen and breast cancer—from palliation to prevention. Cancer Nurs. 1993; 16: 341-346.
6.
Fisher B, Costantino JP: Response: re: tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst. 1999; 91: 1891A-1892A.
7.
Doyle D, Hanks G, MacDonald N: Introduction. In: Doyle D, Hanks G, MacDonald N (eds.): Oxford Textbook of Palliative Medicine. New York: Oxford University Press, 1998, 3.
8.
Carey RW, Davis JM, Zervas NT: Tamoxifen-induced regression of cerebral metastases in breast carcinoma. Cancer Treat Rep. 1981; 65: 793-795.
9.
Glick JH, Wein A, Padavic K, et al.: Phase II trial of tamoxifen in metastatic carcinoma of the prostate. Cancer. 1982; 49: 1367-1372.
10.
Nichols S, Waters WE, Wheeler MJ: Management of female breast disease by Southampton general practitioners. Br Med J. 1980; 281: 1450-1453.
11.
Holland PA, Gateley CA: Drug therapy of mastalgia. What are the options?Drugs. 1994; 48: 709-716.
12.
Fentiman IS, Caleffi M, Hamed H, et al.: Dosage and duration of tamoxifen treatment for mastalgia: A controlled trial. Br J Surg. 1988; 75: 845-846.
13.
Hortobagyi GN: Treatment of breast cancer. N Engl J Med. 1998; 339: 974-984.
